These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27210089)

  • 1. [Efficacy of Levofloxacin Hydrate in Febrile Neutropenia for Outpatient Chemotherapy].
    Inagaki M; Sato J; Nihei S; Kashiwaba M; Kudo K
    Gan To Kagaku Ryoho; 2016 May; 43(5):593-6. PubMed ID: 27210089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia].
    Hata A; Katakami N; Masuda Y; Takashima K; Takeshita J; Tanaka K; Kaji R; Fujita S; Ose T; Kitajima N
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1119-23. PubMed ID: 25248895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen.
    Mogi A; Sasaki H; Nakashima Y; Chinen S; Ishizu M; Tanaka T; Takata T; Takamatsu Y
    J Clin Exp Hematop; 2020 Sep; 60(3):73-77. PubMed ID: 32779614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
    Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
    J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.
    Kurtti A; Fritz K; Elofson-Disney K; Benefield R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1301-1305. PubMed ID: 31810423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
    Pettit N; Boadu D; Bischof JJ
    Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.
    Aarts MJ; Grutters JP; Peters FP; Mandigers CM; Dercksen MW; Stouthard JM; Nortier HJ; van Laarhoven HW; van Warmerdam LJ; van de Wouw AJ; Jacobs EM; Mattijssen V; van der Rijt CC; Smilde TJ; van der Velden AW; Temizkan M; Batman E; Muller EW; van Gastel SM; Joore MA; Borm GF; Tjan-Heijnen VC
    J Clin Oncol; 2013 Dec; 31(34):4283-9. PubMed ID: 24166522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of febrile neutropenia in urological anticancer chemotherapy: retrospective single center study.
    Nishiyama N; Takahashi S; Mizuno T; Uehara T; Hashimoto J; Kurimura Y; Masumori N
    Int J Clin Oncol; 2015 Oct; 20(5):1012-7. PubMed ID: 25652906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
    Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
    Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study.
    Fujita M; Matsumoto T; Inoue Y; Wataya H; Takayama K; Ishida M; Ebi N; Kishimoto J; Ichinose Y;
    J Infect Chemother; 2016 Apr; 22(4):235-9. PubMed ID: 26867793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review.
    Pherwani N; Ghayad JM; Holle LM; Karpiuk EL
    Am J Health Syst Pharm; 2015 Apr; 72(8):619-31. PubMed ID: 25825185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
    Bellesso M; Costa SF; Pracchia LF; Santos Dias LC; Chamone D; Dorlhiac-Llacer PE
    Ann Hematol; 2011 Apr; 90(4):455-62. PubMed ID: 20852999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
    Netterberg I; Karlsson MO; Nielsen EI; Quartino AL; Lindman H; Friberg LE
    Br J Clin Pharmacol; 2018 Mar; 84(3):490-500. PubMed ID: 29178353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.
    Wang L; Barron R; Baser O; Langeberg WJ; Dale DC
    Value Health; 2014 Sep; 17(6):739-43. PubMed ID: 25236998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
    Owattanapanich W; Chayakulkeeree M
    Hematology; 2019 Dec; 24(1):362-368. PubMed ID: 30880638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Fever Advisory Cards (FACs) as an Initiative to Improve Febrile Neutropenia Management in a Regional Cancer Center Emergency Department.
    Kapil P; MacMillan M; Carvalho M; Lymburner P; Fung R; Almeida B; Van Dorn L; Enright K
    J Oncol Pract; 2016 Sep; 12(9):e858-63. PubMed ID: 27486160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.